What's Undetermined It's difficult to determine who was actually responsible for the stunt, given that 3M denies having any involvement and the marketing firm in question has not yet responded to ...

Third Quarter 2024 Results Key Financial Results Revenue: US$33.3m (up 48% ...

Investigations revealed that a French pharmaceutical company fell victim to a business e-mail impersonation scam by the syndicate in March 2020. The firm transferred more than $10 million for what ...

As the Canadian economy experiences a cooling labor market and anticipates further interest rate cuts by the Bank of Canada, financial markets are poised to navigate these shifts with cautious ...

Bruce, Professional Relations Associate, 3M Pharmaceuticals, personal communication, March 2007). Of interest to us were the four subjects (15%) with reactions to fragrance mix. The positive ...

Q3 2024 Earnings Call Transcript November 5, 2024 Operator: Good morning, everyone, and welcome to the Cellectis Third ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good morning and welcome to Sixth Street Specialty Lending, ...

英为财情Investing.com - Supernus Pharmaceuticals (NASDAQ: SUPN)星期一发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.69，总营收为$175.69M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$157.3M，每股收益为 ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

英为财情Investing.com - West Pharmaceutical Services (NYSE: WST)星期四发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$1.85，总营收为$746.9M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$709.3M，每股收益为 ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...